Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121 [Phase 1]
Phase 1 trial comparing pharmacokinetics, pharmacodynamics, and safety of two investigational agents, AD-212-A and AD-2121, in gastroesophag…
-
FDA approval · 2024-08-01FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Fresenius Kabi USA, LLC)
FDA approved Pantoprazole sodium from Fresenius Kabi USA as an original application (ANDA) generic product.
-
CLINICAL_TRIALS withdrawal · 2024-08-01Clinical Trial Update: Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders
Clinical trial update indicates that the expanded access protocol for domperidone in gastrointestinal disorders is no longer available.
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Impact of Gastric Length of Myotomy During POEM on Gastroesophageal Reflux
This completed trial evaluated whether the gastric length of the myotomy during POEM affects postoperative gastroesophageal reflux.
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Effect of Fermented Soybean (FSB) Supplementation on Gas-troesophageal Reflux Disease (GERD) [NA]
A completed clinical trial assessing whether fermented soybean supplementation (FSB) affects gastroesophageal reflux disease (GERD).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers [NA]
Clinical trial compares pharmacodynamics and pharmacodynamic equivalence of Antareit 800 mg/10 ml oral suspension and Riopan 800 mg chewable…
-
FDA approval · 2024-07-17FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for esomeprazole magnesium by Somerset Therapeutics, LLC.
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Gastroesophageal Reflux Disease Diagnostic Trial
A diagnostic trial for gastroesophageal reflux disease sponsored by Changhai Hospital is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: "The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences in the Voice?
A clinical trial investigating the effect of gastric reflux on irritation of the vocal folds and whether reflux-related voice changes differ…
-
FDA approval · 2024-07-05FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Lansoprazole from Mylan Pharmaceuticals Inc. under an existing ANDA, approving a generic version…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects [Phase 1]
This Phase 1 trial compared the pharmacokinetics, pharmacodynamics, and safety of UI058 and UIC202004 in healthy subjects; the study has com…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants [Phase 1]
A first-in-human Phase 1 study comparing a bi-layer calcium carbonate antacid tablet with a standard non-layered calcium carbonate tablet in…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Zuojin Wan Combined With Woonosan Fumarate for the Treatment of GRD Combined With Depression [NA]
A clinical trial is evaluating the combination of Zuojin Wan with Woonosan Fumarate for gastroesophageal reflux disease with depression. The…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Combined Scalp and Ear Acupuncture in Patients With Proton Pump Inhibitor- Dependent Gastroesophageal Reflux Disease [NA]
A ClinicalTrials.gov update indicates that the study evaluating combined scalp and ear acupuncture for proton pump inhibitor–dependent gastr…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy [NA]
A clinical trial update describes a study evaluating the diagnostic yield of postprandial high-resolution impedance manometry in patients wi…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Effect of Helicobacter Pylori Eradication on Gastroesophageal RefIux Disease (GERD)
A clinical trial from Assiut University is evaluating whether eradicating Helicobacter pylori affects outcomes in patients with gastroesopha…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: How Reflux Medications Affect the Microbiome of Infants
This completed clinical trial investigates how reflux medications affect the gut microbiome in infants with gastroesophageal reflux disease.
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease [Phase 1]
A Phase 1 study evaluating the pharmacokinetics, pharmacodynamics, and safety of vonoprazan in adolescents with symptomatic gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection [Phase 1]
A Phase 1 trial to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of DWP14012 injection in erosive gastroesophageal r…
-
FDA approval · 2024-05-28FDA Approved: FAMOTIDINE — Original Application (LEADER/ Cardinal Health 110, Inc.)
FDA approved the original ANDA for famotidine from LEADER/ Cardinal Health 110, Inc., providing a generic version of famotidine.
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Efficacy and Safety of EsoDuo® [Phase 4]
Phase 4 clinical trial of EsoDuo for gastroesophageal reflux disease is currently recruiting; there are no efficacy or safety results report…
-
FDA approval · 2024-05-14FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approves a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Inc., authorizing changes to an existing generic prod…
-
FDA approval · 2024-05-03FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole from Mylan Pharmaceuticals Inc., indicating an amendment to the approved generic pr…
-
FDA approval · 2024-04-30FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' esomeprazole magnesium as a generic product under an Original Application (ANDA 207198). The approval…
-
FDA approval · 2024-04-23FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for pantoprazole sodium (generic pantoprazole) from Ajanta Pharma USA Inc. under ANDA217416.